383 Stock Overview
An investment holding company, primarily operates hospitals in the People’s Republic of China and Hong Kong.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Tian An Medicare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.69 |
| 52 Week High | HK$0.98 |
| 52 Week Low | HK$0.60 |
| Beta | 0.82 |
| 1 Month Change | 1.47% |
| 3 Month Change | -1.43% |
| 1 Year Change | -21.59% |
| 3 Year Change | -71.25% |
| 5 Year Change | -75.36% |
| Change since IPO | 731.53% |
Recent News & Updates
Recent updates
China Medical & HealthCare Group's (HKG:383) Returns On Capital Not Reflecting Well On The Business
Feb 02
Returns On Capital Signal Difficult Times Ahead For China Medical & HealthCare Group (HKG:383)
Oct 26Is China Medical & HealthCare Group (HKG:383) Using Debt In A Risky Way?
Sep 30China Medical & HealthCare Group (HKG:383) Might Have The Makings Of A Multi-Bagger
Dec 10We Think China Medical & HealthCare Group (HKG:383) Has A Fair Chunk Of Debt
Apr 08Do Institutions Own China Medical & HealthCare Group Limited (HKG:383) Shares?
Feb 14
Is China Medical & HealthCare Group (HKG:383) A Risky Investment?
Dec 22Shareholder Returns
| 383 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | 1.5% | -1.2% | -2.3% |
| 1Y | -21.6% | -22.7% | 0.3% |
Return vs Industry: 383 exceeded the Hong Kong Healthcare industry which returned -22.7% over the past year.
Return vs Market: 383 underperformed the Hong Kong Market which returned 0.3% over the past year.
Price Volatility
| 383 volatility | |
|---|---|
| 383 Average Weekly Movement | 3.2% |
| Healthcare Industry Average Movement | 6.1% |
| Market Average Movement | 7.3% |
| 10% most volatile stocks in HK Market | 15.7% |
| 10% least volatile stocks in HK Market | 3.8% |
Stable Share Price: 383 has not had significant price volatility in the past 3 months.
Volatility Over Time: 383's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 2,599 | n/a | www.tiananmedicare.com.hk |
Tian An Medicare Limited, an investment holding company, primarily operates hospitals in the People’s Republic of China and Hong Kong. It operates through six segments: Healthcare, Eldercare, Property Development, Property Investment, Financial Services, and Securities Trading and Investments. The company also involved in property development of independent living units and project management of health campus with a focus on eldercare and retirement community including elderly nursing home, service apartments, independent living units and commercial area comprising shopping mall, retail shops, and club hall facilities.
Tian An Medicare Limited Fundamentals Summary
| 383 fundamental statistics | |
|---|---|
| Market cap | HK$749.34m |
| Earnings (TTM) | HK$11.30m |
| Revenue (TTM) | HK$1.57b |
66.3x
P/E Ratio0.5x
P/S RatioIs 383 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 383 income statement (TTM) | |
|---|---|
| Revenue | HK$1.57b |
| Cost of Revenue | HK$1.29b |
| Gross Profit | HK$278.12m |
| Other Expenses | HK$266.83m |
| Earnings | HK$11.30m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.01 |
| Gross Margin | 17.73% |
| Net Profit Margin | 0.72% |
| Debt/Equity Ratio | 39.8% |
How did 383 perform over the long term?
See historical performance and comparison